Interestingly, in the examined data from stomach adenocarcinoma, specifically those from stage 2, 3, and 4 tumors, SMYD4 exhibited higher expression levels compared to normal samples in most patients. The gene discussed is SMYD4; the disease is gastric adenocarcinoma.